From: Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV
 | HIV-infected, N (%) | HIV-uninfected, N (%) | p-value |
---|---|---|---|
 | 22 (22) | 78 (78) |  |
Age groups (in years) | |||
18–34 | 5 (23) | 23 (29.5) | 0.003 |
35–49 | 14 (64) | 18 (23) | |
50–59 | 2 (9) | 23 (29.5) | |
60–90 | 1 (5) | 14 (18) | |
Gender | Â | ||
Male | 14 (64) | 64 (72) | 0.03 |
Female | 8 (36) | 14 (18) | |
Race | |||
African | 20 (91) | 32 (43) | 0.0004 |
Caucasian | 0 (0.0) | 6 (8) | |
Mixed | 2 (9) | 36 (49) | |
Missing dataa | 0 | 4 | |
Place of birth | |||
Urban | 14 (70) | 44 (60) | 0.4 |
Rural | 6 (30) | 29 (40) | |
Missing dataa | 2 | 5 | |
Alcohol dependence | |||
Yes | 5 (24) | 15 (21) | 0.7 |
No | 16 (76) | 57 (79) | |
Missing dataa | 1 | 6 | |
Known cirrhosis | |||
Yes | 5 (25) | 15 (22) | 0.8 |
No | 15 (75) | 52 (78) | |
Missing dataa | 2 | 11 | |
HBsAg status | |||
Positive | 18 (82) | 47 (60) | 0.06 |
Negative | 4 (18) | 31 (40) | |
Anti-HBc status | |||
Positive | 20 (91) | 62 (83) | 0.5 |
Negative | 2 (9) | 13 (17) | |
Missing dataa | 0 | 3 | |
Anti-HCV | |||
Positive | 1 (5) | 7 (9) | 0.7 |
Negative | 20 (95) | 68 (91) | |
Missing dataa | 1 | 3 |